Efthymios Dardiotis
Overview
Explore the profile of Efthymios Dardiotis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patrikiou E, Efthymiou G, Liaskos C, Ntavari N, Scheper T, Meyer W, et al.
Immunol Res
. 2024 Dec;
73(1):22.
PMID: 39702701
Helicobacter pylori (Hp) has been postulated as an infectious trigger of psoriatic disease, namely psoriasis (Ps) and psoriatic arthritis (PsA), but meticulous antibody (ab) reactivity against all dominant and subdominant...
2.
Unraveling the intricate dance of the Mediterranean diet and gut microbiota in autoimmune resilience
Tsigalou C, Tsolou A, Stavropoulou E, Konstantinidis T, Zafiriou E, Dardiotis E, et al.
Front Nutr
. 2024 May;
11:1383040.
PMID: 38818135
The nutritional habits regulate the gut microbiota and increase risk of an autoimmune disease. Western diet is rich in sugars, meat, and poly-unsaturated fatty acids, which lead to dysbiosis of...
3.
Tsiogkas S, Tsimourtou V, Chaidaki K, Dardiotis E, Roussaki-Schulze A, Bogdanos D, et al.
J Dermatol
. 2024 Feb;
51(6):844-848.
PMID: 38345289
Biologics approved for psoriasis exhibit favorable safety profiles, and serious adverse events have rarely been reported. In this report, we present the case of a patient treated with ixekizumab, an...
4.
Lazari K, Androudi S, Dardiotis E, Tsironi E, Papageorgiou E
Clin Exp Optom
. 2023 Sep;
107(7):764-766.
PMID: 37674269
No abstract available.
5.
Dardiotis E, Perpati G, Borsos M, Nikolaidis I, Tzanetakos D, Deretzi G, et al.
Neurol Ther
. 2022 Jul;
11(3):1375-1390.
PMID: 35829919
Introduction: Multiple sclerosis (MS) is a highly heterogeneous inflammatory disease of the central nervous system. Patient-reported outcomes (PROs) in a real-world clinical setting can provide detailed information about MS from...
6.
Gontika M, Skarlis C, Markoglou N, Tzanetakos D, Vakrakou A, Toulas P, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2022 Apr;
395(8):933-943.
PMID: 35471586
Pediatric-onset multiple sclerosis (MS, POMS) accounts for 3-5% of all MS cases and is characterized by a highly inflammatory profile, often warranting treatment with high-efficacy agents. Our aim is to...
7.
Tsivgoulis G, Triantafyllou S, Palaiodimou L, Mac Grory B, Deftereos S, Kohrmann M, et al.
Neurology
. 2022 Mar;
98(19):e1942-e1952.
PMID: 35264426
Background And Objectives: Prolonged poststroke cardiac rhythm monitoring (PCM) reveals a substantial proportion of patients with ischemic stroke (IS) with atrial fibrillation (AF) not detected by conventional rhythm monitoring strategies....
8.
Florou D, Mavropoulos A, Dardiotis E, Tsimourtou V, Siokas V, Aloizou A, et al.
Front Immunol
. 2021 Dec;
12:739186.
PMID: 34899697
Introduction: Limited data from clinical trials in multiple sclerosis (MS) reported that minocycline, a widely used antibiotic belonging to the family of tetracyclines (TCs), exerts a beneficial short-lived clinical effect...
9.
Liampas A, Nteveros A, Parperis K, Akil M, Dardiotis E, Andreadou E, et al.
Acta Neurol Belg
. 2021 Oct;
123(5):2051.
PMID: 34709595
No abstract available.
10.
Liampas A, Nteveros A, Parperis K, Akil M, Dardiotis E, Andreadou E, et al.
Acta Neurol Belg
. 2021 Oct;
122(2):457-463.
PMID: 34611842
Background: Primary Sjögren's syndrome (pSS) is a chronic autoimmune disorder characterized by lymphocytic infiltrates of the exocrine glands, particularly the salivary and lacrimal glands, resulting in oral and ocular dryness....